Bio-key International, Inc. (BKYI) Cash Flow Statement

Click line-items for a historical chart and %

Net income (loss)	-3.67M
Income from discontinued operations
Income (loss) from continuing operations
Derivative and warrant fair value adjustments
Depreciation	37.76K
Intangible assets	10.21K
Discount on convertible debt related to derivatives
Discount on secured debt	0
Net discounts of notes payable and note receivable
Share-based compensation	231.98K
Accounts receivable trade	957.02K
Inventory	-219.59K
Prepaid expenses and other	-39.21K
Accounts payable	-607.75K
Accrued liabilities	-156K
Deferred revenue	-136.25K
Net cash used for continuing operations	-3.52M
Net provided by discontinued operations
Net cash used for operating activities
Capital expenditures	-52.98K
Transfer of funds from restricted cash
Net cash provided by (used for) investing activities
Repayment of notes payable
Proceeds from payment of note receivable
Dividends paid
Net cash used for financing activities
NET DECREASE IN CASH AND CASH EQUIVALENTS	-4.14M
CASH AND CASH EQUIVALENTS, BEGINNING OF PERIOD	4.32M
CASH AND CASH EQUIVALENTS, END OF PERIOD	177.39K
Interest	0

Entities mentioned with BKYI

View All Entities